Moderna, Inc. Stock Performance
as on December 12, 2025 at 2:29 am IST
Day's Low
Day's High
$28.88$29.68
2.50%
Downside
0.20%
Upside
52 Week's Low
52 Week's High
$22.28$48.9224.78%
Downside
65.16%
Upside
Moderna, Inc. share price movements today
- Previous Close
- $29.03
- Open
- $28.95
- Volume
- 7.9M
- Day's Low - High
- $28.88 - $29.68
- 52 Week Low - High
- $22.28 - $48.92
Moderna, Inc. Historical Returns
- 1 Month Return
- + 10.93 %
- 3 Month Return
- + 26.03 %
- 1 Year Return
- -30.8 %
- 3 Year Return
- -82.06 %
- 5 Year Return
- -81.12 %
Moderna, Inc. Stock Fundamentals & Key Indicators
Check Moderna, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$11.3B
EPS (TTM)
-8.1869
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.85%
PE Ratio (TTM)
-5.08
Industry PE ratio
19.200384615384614
PEG Ratio
0EBITDA
-3.3B
Revenue (TTM)
2.2B
Profit Margin
-139.61%
Return On Equity TTM
-29.32%
Moderna, Inc. Stock Valuation
Track how Moderna, Inc. P/E has moved over time to understand its valuation trends.
Moderna, Inc. in the last 5 years
Lowest (-52.15x)
December 31, 2020
Today (-5.08x)
December 12, 2025
Industry (19.20x)
December 12, 2025
Highest (115.93x)
March 31, 2021
Today’s Price to Earnings Ratio: -5.08x
Moderna, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Moderna, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $11.3B | -81.12% | -5.08 | -139.61% | |
| BUY | $41.6B | 389.45% | -16.34 | -264.83% | |
| BUY | $53.4B | 218.26% | 1444.5 | 1.36% | |
| BUY | $114.0B | 98.92% | 31.25 | 31.35% | |
| BUY | $77.0B | 55.66% | 17.42 | 32.13% |
Stock Returns calculator for Moderna, Inc. Stock including INR - Dollar returns
The Moderna, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moderna, Inc. investment value today
Current value as on today
₹75,736
Returns
Returns from Moderna, Inc. Stock
Dollar Returns*
₹6,563 (+6.56%)
Analyst Recommendation on Moderna, Inc. Stock
Based on 31 analysts
54.84%
Buy
35.48%
Hold
9.68%
Sell
Based on 31 analysts, 54.84% of analysts recommend a 'BUY' rating for Moderna, Inc.. Average target price of $35.78
Moderna, Inc. Share Price Target
Get share price movements and forecasts by analysts on Moderna, Inc..
What analysts predicted
17.22%UPSIDE
Target Price
$35.78
Current Price
$29.62
Analyzed by
31 Analysts
Target
$35.78
Moderna, Inc. target price $35.78, a slight upside of 17.22% compared to current price of $29.62. According to 31 analysts rating.
Moderna, Inc. Stock’s Investor Sentiment and Interest
Investment in Moderna, Inc. Shares on INDmoney has dropped by -41.69% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Moderna, Inc. Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:34% versus previous 30 day period
Moderna, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Moderna, Inc. Annual Profit & Loss
All numbers in Millions USD
Moderna, Inc. Quarterly Cash Flow
All numbers in Millions USD
Moderna, Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Moderna, Inc. Stock
Check out the Mutual Funds with significant holdings in Moderna, Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.01528% | 2698 |
Global Institutional Holdings in Moderna, Inc.
Moderna, Inc. News & Key Events
Today's Timeline - 11 December
Thu, 06:14 PM
-Moderna secures a $1.5 billion loan to support business development and anticipates 10% revenue growth in 2026.
Thu, 11:17 PM
-New options for January 2026 trading introduced for Moderna, with significant put and call contract details.
Thu, 11:30 PM
-Moderna's short interest rises to 21.18%, indicating bearish sentiment among traders.
Today's Timeline - 11 December
Fri, 00:09 AM
-Ongoing litigation with Genevant; U.S. jury trial with Moderna scheduled for March 2026.
Insights on Moderna, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 107.0M → 1.01B (in $), with an average increase of 55.3% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -1.12B → -200.0M (in $), with an average increase of 115.2% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Insmed Incorporated has given 171.0% return, outperforming this stock by 201.8%
- NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 908.0% return, outperforming this stock by 990.1%
NEGATIVE IMPACTPrice Dip
In the last 3 years, MRNA stock has moved down by -82.1%
About Moderna, Inc.
| Organisation | Moderna, Inc. |
| Headquarters | 325 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. Stéphane Bancel |
| E-voting on shares | Click here to vote |
Key Management of Moderna, Inc.
Name | Title |
|---|---|
Ms. Shannon Thyme Klinger J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Tracey Franklin | Chief People & Digital Technology Officer |
Mr. Dave Johnson | Chief Data & AI Officer |
Dr. Charbel Haber M.P.H., Ph.D. | Senior VP & Head of Global Regulatory Science |
Mr. Stéphane Bancel | CEO & Director |
Dr. Stephen Hoge M.D. | President |
Mr. James M. Mock | Chief Financial Officer |
Dr. Jerh Collins Ph.D. | Chief Technical Operations & Quality Officer |
Ms. Lavina Talukdar CFA | Senior VP & Head of Investor Relations |
Dr. Melanie Ivarsson M.B.A., O.B.E., Ph.D. | Chief Development Officer |
FAQs
What is Moderna, Inc. share price today?
Moderna, Inc. share price today is $29.62 as on at the close of the market. Moderna, Inc. share today touched a day high of $29.68 and a low of $28.88.
What is the 52 week high and 52 week low for Moderna, Inc. share?
Moderna, Inc. share touched a 52 week high of $48.92 on and a 52 week low of $22.28 on . Moderna, Inc. stock price today i.e. is closed at $29.62,which is 39.45% down from its 52 week high and 32.94% up from its 52 week low.
What is Moderna, Inc.'s market capitalisation today?
Moderna, Inc. market capitalisation is $0.01T as on .
How to invest in Moderna, Inc. Stock (MRNA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Moderna, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moderna, Inc. Shares that will get you 0.0506 shares as per Moderna, Inc. share price of $29.62 per share as on December 12, 2025 at 2:29 am IST.
What is the minimum amount required to buy Moderna, Inc. Stock (MRNA) from India?
Indian investors can start investing in Moderna, Inc. (MRNA) shares with as little as ₹90.397 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹903.97 in Moderna, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moderna, Inc. share’s latest price of $29.62 as on December 12, 2025 at 2:29 am IST, you will get 0.3376 shares of Moderna, Inc.. Learn more about
fractional shares .
What are the returns that Moderna, Inc. has given to Indian investors in the last 5 years?
Moderna, Inc. stock has given -81.12% share price returns and 22.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?